patents
Forecasts show branded generics will double in revenue with Asia driving growth
February 13, 2020Business Services branded drugs, drug patents, patents
Branded generic drugs are expected to grow in global sales by 8% by 2029, but Europe and America will not …
Gilead challenges Government over patents on preventative HIV drug Truvada
August 22, 2019Research and Development, Sales and Marketing AIDS, CDC, Gilead, HIV, IP, PrEP, Truvada, government, patents
Gilead is challenging the US Government’s patents on PrEP drug Truvada. The Foster City firm has submitted a challenge to …
China urges firms to make generic versions of 34 drugs
June 25, 2019Research and Development China, NHC, generic drugs, generics, patents, pharma
China’s National Health Commission (NHC) has urged generic drugmakers to pick up the production of 34 drugs that are not …
Gilead accused of ripping off US taxpayers
March 28, 2019Medical Communications, Sales and Marketing CDC, Gilead, HIV, PrEP, Truvada, US government, patents
Gilead have been accused of ‘ripping off’ US taxpayers after the firm was revealed to have generated $3 billion in …
Repurposed drugs: The Supreme Court deals a blow to patentees
January 31, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Supreme Court, drug repurposing, feature, patents, pharma
Second medical use patents protect the discovery that an existing drug is effective to treat a new condition. But, following …
Allergan and St Regis Mohawk Tribe take patent ruling to Supreme Court
January 28, 2019Sales and Marketing Allergan, Mohawk, Restasis, St Regis, eye drops, patents
Allergan and the St Regis Mohawk Tribe have asked the Supreme Court to defend a 2017 patent agreement which would …
Fewer patents being filed for novel infectious diseases and AMR diagnostic technologies; US leads, UK follows
October 17, 2018Research and Development AMR, IP, intellectual property, patents
Fewer patents are being filed for point-of-care diagnostic technologies aimed at tackling infectious diseases and antimicrobial resistance (AMR), according to …
AbbVie suffers knock to Humira patent
May 19, 2017Medical Communications, Sales and Marketing AbbVie, Humira, patents
Humira is the largest selling pharmaceutical drug in the world. The treatment for rheumatoid arthritis brought in over $16 billion …
In-depth: MSF takes on Pfizer, GSK
May 3, 2016Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Doctors Without Borders, GSK, Pfizer, analysis, medicins sans frontieres, patents, pneumonia
Medicins Sans Frontieres (MSF) recently stepped up their campaign to make the pneumonia vaccine more available in developing countries. Appearing …
Federal jury rules in MSD’s favour in Gilead blockbuster hepatitis C drug dispute
March 23, 2016Medical Communications, Research and Development Gilead, MSD, blockbuster, federal court, federal jury, hit, patents, sales, sales hit, sofosbuvir, sovaldi
Gilead’s dominance of the hepatitis C market is under severe threat after a federal jury ruled in favour of MSD …
Delivering successful new drugs
March 1, 2016Manufacturing and Production, Sales and Marketing AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Pfizer, patents, pharma
Pharma companies are struggling with challenges specific to their industry. Patents for many drugs, that had created massive amounts of …
US Federal Trade Commission clamps down on pharma ‘pay to delay’ deals
January 14, 2016Manufacturing and Production, Sales and Marketing Pay to delay, US Supreme Court, antitrust laws, federal trade commission, generic competition, generics, patents, pay for delay
Pharma companies were able to negotiate far fewer so-called ‘pay to delay’ cases as a strategy to stave off generic …
Celgene settles Revlimid patent dispute
December 23, 2015Manufacturing and Production, Research and Development, Sales and Marketing Celgene, India, Natco, Revlimid, lenalidomide, patents
Celgene has settled its litigation with Natco Pharma, over the patents for Revlimid, opening the door to increased generic competition …
Patents prompting ‘rebirth’ of innovation in industry
November 13, 2015Medical Communications innovation, patents, pharma
Seven pharma companies have been rated among the world’s 100 most innovative companies, according to Thomson Reuters.The business intelligence firm …
Putting off-patent drugs back to work
November 4, 2015Research and Development, Sales and Marketing Off-Patent Drugs Bill, Professor Paul Workman, The ICR, The ICR London, drug repurposing, patents
Six clinicians here at The Institute of Cancer Research, London, have joined colleagues from across the UK in writing to …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
